MA24346A1 - Procede pour la preparation de composes anti-inflammatoires et analgesiques - Google Patents
Procede pour la preparation de composes anti-inflammatoires et analgesiquesInfo
- Publication number
- MA24346A1 MA24346A1 MA24642A MA24642A MA24346A1 MA 24346 A1 MA24346 A1 MA 24346A1 MA 24642 A MA24642 A MA 24642A MA 24642 A MA24642 A MA 24642A MA 24346 A1 MA24346 A1 MA 24346A1
- Authority
- MA
- Morocco
- Prior art keywords
- inflammatory
- preparation
- analgesic compounds
- analgesic
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D207/33—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D207/333—Radicals substituted by oxygen or sulfur atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Immunology (AREA)
- Public Health (AREA)
- Pulmonology (AREA)
- Transplantation (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrrole Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US1869196P | 1996-05-30 | 1996-05-30 |
Publications (1)
Publication Number | Publication Date |
---|---|
MA24346A1 true MA24346A1 (fr) | 1998-07-01 |
Family
ID=21789298
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA24642A MA24346A1 (fr) | 1996-05-30 | 1997-05-30 | Procede pour la preparation de composes anti-inflammatoires et analgesiques |
Country Status (21)
Country | Link |
---|---|
US (3) | US5952368A (fr) |
EP (1) | EP0906279B1 (fr) |
JP (1) | JP3142581B2 (fr) |
KR (1) | KR100303377B1 (fr) |
CN (1) | CN1225629A (fr) |
AR (1) | AR007297A1 (fr) |
AT (1) | ATE225333T1 (fr) |
AU (1) | AU717602B2 (fr) |
BR (1) | BR9709497A (fr) |
CA (1) | CA2256609C (fr) |
CO (1) | CO4960660A1 (fr) |
DE (1) | DE69716061T2 (fr) |
DK (1) | DK0906279T3 (fr) |
ES (1) | ES2182090T3 (fr) |
HR (1) | HRP970296A2 (fr) |
MA (1) | MA24346A1 (fr) |
PT (1) | PT906279E (fr) |
TR (1) | TR199802456T2 (fr) |
TW (1) | TW415946B (fr) |
WO (1) | WO1997046524A1 (fr) |
ZA (1) | ZA974538B (fr) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003063796A2 (fr) * | 2002-01-30 | 2003-08-07 | Tularik Inc. | Composes arylsulfonamidobenzyliques heterocycliques |
TWI372050B (en) * | 2003-07-03 | 2012-09-11 | Astex Therapeutics Ltd | (morpholin-4-ylmethyl-1h-benzimidazol-2-yl)-1h-pyrazoles |
WO2005123671A1 (fr) * | 2004-06-22 | 2005-12-29 | Taisho Pharmaceutical Co., Ltd. | Dérivé du pyrrole |
US8110573B2 (en) * | 2004-12-30 | 2012-02-07 | Astex Therapeutics Limited | Pyrazole compounds that modulate the activity of CDK, GSK and aurora kinases |
US8399442B2 (en) * | 2005-12-30 | 2013-03-19 | Astex Therapeutics Limited | Pharmaceutical compounds |
EP2049119A2 (fr) * | 2006-06-29 | 2009-04-22 | Astex Therapeutics Limited | Combinaisons pharmaceutiques du 1-cyclopropyl-3-[3-(5-morphoolin-4-ylmethyl-1h-benzoimidazol-2-yl)-1h-1-pyrazol-4-yl]-urea |
EP2043635A2 (fr) * | 2006-06-29 | 2009-04-08 | Astex Therapeutics Limited | Combinaisons pharmaceutiques |
US10358408B2 (en) * | 2017-12-22 | 2019-07-23 | Polycarbon Industries, Inc. | Synthesis of azelaic acid |
CA3209491A1 (fr) | 2021-03-15 | 2022-09-22 | Saul Yedgar | Dipalmitoyl-phosphatidyl-ethanol-amine conjuguee a l'acide hyaluronique en combinaison avec des medicaments anti-inflammatoires non steroidiens (ains) pour traiter ou soulager des maladies inflammatoire |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3752826A (en) * | 1970-01-26 | 1973-08-14 | Mcneilab Inc | Aroyl substituted pyrroles |
US4089969A (en) * | 1976-07-14 | 1978-05-16 | Syntex (U.S.A.) Inc. | 5-Aroyl-1,2-dihydro-3H-pyrrolo[1,2-a]pyrrole-1-carboxylic acid derivatives and process for the production thereof |
KR840000486A (ko) * | 1981-07-22 | 1984-02-22 | 원본미기재 | 치환된 피롤리딘의 제조방법 |
IL86462A (en) * | 1987-05-29 | 1992-12-01 | Fujisawa Pharmaceutical Co | Alkanesulfonanilide derivatives, processes for preparation thereof and pharmaceutical compositions comprising the same |
US5622948A (en) * | 1994-12-01 | 1997-04-22 | Syntex (U.S.A.) Inc. | Pyrrole pyridazine and pyridazinone anti-inflammatory agents |
-
1997
- 1997-05-21 AU AU30913/97A patent/AU717602B2/en not_active Ceased
- 1997-05-21 JP JP10500147A patent/JP3142581B2/ja not_active Expired - Fee Related
- 1997-05-21 TR TR1998/02456T patent/TR199802456T2/xx unknown
- 1997-05-21 DK DK97925931T patent/DK0906279T3/da active
- 1997-05-21 BR BR9709497A patent/BR9709497A/pt unknown
- 1997-05-21 CA CA002256609A patent/CA2256609C/fr not_active Expired - Fee Related
- 1997-05-21 PT PT97925931T patent/PT906279E/pt unknown
- 1997-05-21 DE DE69716061T patent/DE69716061T2/de not_active Expired - Fee Related
- 1997-05-21 KR KR1019980709759A patent/KR100303377B1/ko not_active IP Right Cessation
- 1997-05-21 CN CN97196566A patent/CN1225629A/zh active Pending
- 1997-05-21 EP EP97925931A patent/EP0906279B1/fr not_active Expired - Lifetime
- 1997-05-21 WO PCT/EP1997/002587 patent/WO1997046524A1/fr active IP Right Grant
- 1997-05-21 AT AT97925931T patent/ATE225333T1/de not_active IP Right Cessation
- 1997-05-21 ES ES97925931T patent/ES2182090T3/es not_active Expired - Lifetime
- 1997-05-23 ZA ZA9704538A patent/ZA974538B/xx unknown
- 1997-05-27 AR ARP970102246A patent/AR007297A1/es not_active Application Discontinuation
- 1997-05-28 HR HR60/018,691A patent/HRP970296A2/xx not_active Application Discontinuation
- 1997-05-28 US US08/864,703 patent/US5952368A/en not_active Expired - Fee Related
- 1997-05-28 CO CO97029326A patent/CO4960660A1/es unknown
- 1997-05-29 TW TW086107344A patent/TW415946B/zh not_active IP Right Cessation
- 1997-05-30 MA MA24642A patent/MA24346A1/fr unknown
-
1999
- 1999-03-24 US US09/275,540 patent/US6127402A/en not_active Expired - Fee Related
- 1999-03-24 US US09/275,542 patent/US6136844A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CO4960660A1 (es) | 2000-09-25 |
PT906279E (pt) | 2003-02-28 |
HRP970296A2 (en) | 1998-04-30 |
AU717602B2 (en) | 2000-03-30 |
TW415946B (en) | 2000-12-21 |
AR007297A1 (es) | 1999-10-27 |
DE69716061T2 (de) | 2003-08-14 |
WO1997046524A1 (fr) | 1997-12-11 |
ES2182090T3 (es) | 2003-03-01 |
TR199802456T2 (xx) | 1999-02-22 |
US6136844A (en) | 2000-10-24 |
ZA974538B (en) | 1997-12-01 |
AU3091397A (en) | 1998-01-05 |
ATE225333T1 (de) | 2002-10-15 |
US6127402A (en) | 2000-10-03 |
KR20000016191A (ko) | 2000-03-25 |
KR100303377B1 (ko) | 2001-12-12 |
CA2256609C (fr) | 2005-07-26 |
DE69716061D1 (de) | 2002-11-07 |
JP3142581B2 (ja) | 2001-03-07 |
CN1225629A (zh) | 1999-08-11 |
EP0906279A1 (fr) | 1999-04-07 |
US5952368A (en) | 1999-09-14 |
JPH11511755A (ja) | 1999-10-12 |
EP0906279B1 (fr) | 2002-10-02 |
DK0906279T3 (da) | 2003-02-03 |
BR9709497A (pt) | 1999-08-10 |
CA2256609A1 (fr) | 1997-12-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MA24426A1 (fr) | Procede pour la preparation de nouveaux composes | |
MA23792A1 (fr) | Procede pour la preparation de nouveaux composes | |
MA24011A1 (fr) | Procede pour la preparation de nouveaux composes | |
MA23802A1 (fr) | Procede pour la preparation de nouveaux composes | |
MA24205A1 (fr) | Procede pour la preparation du sildenafil | |
MA23254A1 (fr) | Procede de preparation de nouveaux composes | |
MA22923A1 (fr) | Procede de preparation de nouveaux composes . | |
MA24427A1 (fr) | Procede pour la preparation de nouveaux composes | |
MA24437A1 (fr) | Procede de la preparation et de la formulation de dihydrate d'eprosartan | |
MA22955A1 (fr) | Procede pour la preparation de nouveaux composes . | |
MA24355A1 (fr) | Procede de preparation de nouveaux composes | |
FR2781801B1 (fr) | Procede pour la preparation de dianhydride pyromellique | |
MA24401A1 (fr) | Procede pour la preparation de pyridines substitues et intemediaires utilisees a cette fin | |
MA24346A1 (fr) | Procede pour la preparation de composes anti-inflammatoires et analgesiques | |
MA24183A1 (fr) | Procede pour la preparation de compositions pharmaceutiques a base de diclofenac | |
MA23663A1 (fr) | Procede de preparation de formulations pharmaceutiques | |
FR2754816B1 (fr) | Procede de purification d'hydrogenochlorofluoroethanes | |
MA23036A1 (fr) | Procede pour la preparation de composes. | |
MA24245A1 (fr) | Procede pour la preparation de nouveaux composes sulfonylures | |
FR2768725B1 (fr) | Procede de preparation du 2-chloroprop-1-ene | |
FR2715656B1 (fr) | Procédé de préparation d'anhydride citraconique. | |
MA24214A1 (fr) | Procede pour la preparation de nouveaux composes et pour la preparation de compositions pharmaceutiques les contenant | |
MA24831A1 (fr) | Procede pour la preparation d'acides hydroxamiques | |
MA23081A1 (fr) | Procede de preparation de derives d'indolone | |
FR2736645B1 (fr) | Procede de preparation discontinue de polylaurinelactame |